Metformin Promotes Osteogenic Differentiation of Adipose-Derived Stem Cells in Diabetic Osteoporosis by Regulating Autophagy.
Cao H., Li Q., Gao Y., Li J., Yu P., Lan X.
Prospective Study on Face & Skin, Systemic / IV, published in Cell Biol Int (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Cell Biol Int (2025)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 40631901
- DOI
- 10.1002/cbin.70061
Abstract (original English)
Patients with diabetic osteoporosis (DOP) face significant challenges in bone defect repair and regeneration. Adipose-derived stem cells (ASCs) have been widely used in bone tissue engineering due to their accessibility and multi-potency. However, DOP-ASCs exhibit lower capacity for osteogenic differentiation compared to control ASCs (CON-ASCs). In this study, we explored the effects of metformin (Met) on the autophagy and osteogenic capacity of DOP-ASCs. DOP mouse model was established with a high-fat and high-glucose diet combined with streptozotocin injection. After treating DOP-ASCs with Met and 3-methyladenine (3-MA), changes in autophagy levels and osteogenic differentiation capacity were observed by western blot analysis, real-time quantitative PCR (qPCR), immunofluorescence, alkaline phosphatase staining, alizarin red staining, and GFP-LC3 fluorescence labeling analysis. DOP-ASCs were cocultured with the Biphasic Calcium Phosphate (BCP), and implanted into the cranial defect area of DOP mice. The mice then received oral Met and intraperitoneal 3-MA injections for 3 months. The implanted BCP was assessed by micro-CT, HE and Masson staining. We observed a significantly reduced autophagic levels and capacity for osteogenic differentiation in DOP-ASCs, as compared to CON-ASCs. Met activated autophagy in DOP-ASCs and improved their osteogenic differentiation capacity. Howeve
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Oncologic safety of autologous fat grafting in head and neck cancer patients: A scoping review.
Systematic Review with a reported sample of 116 on Face & Skin, published in Med Oral Patol Oral Cir Bucal (2026) — summary generated from the PubMed abstract.
- 2026
- n = 116
Med Oral Patol Oral Cir Bucal - Level ASystematic ReviewEurope PMC
Stem cell-derived exosomes in tissue regeneration of oral and maxillofacial region: A systematic review
Systematic Review on Chronic Wound, published in Medicine (Baltimore) (2026) — summary generated from the PubMed abstract.
- 2026
Medicine (Baltimore) - Level AMeta-analysisPubMed
Stromal Vascular Fraction-Assisted Fat Grafting: A Systematic Review and Meta-analysis of Clinical Outcomes.
Meta-analysis on Face & Skin, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.
- 2026
Aesthetic Plast Surg - Level ASystematic ReviewEurope PMC
Applications of Exosomes in Female Medicine: A Systematic Review of Molecular Biology, Diagnostic and Therapeutic Perspectives
Systematic Review on Face & Skin, Systemic / IV, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci2 citations - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Osteogenic and Biocompatibility Potential of Polylactic Acid-Based Materials: A Systematic Review of Human Primary Cells Studies
Systematic Review on Face & Skin, published in J Funct Biomater (2026) — summary generated from the PubMed abstract.
- 2026
J Funct Biomater